These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

104 related items for PubMed ID: 6888161

  • 1. Caerulein, a cholecystokinin-related peptide, depresses somatic function via the vagal afferent system.
    Kawasaki K, Kodama M, Matsushita A.
    Life Sci; 1983 Sep 12; 33(11):1045-50. PubMed ID: 6888161
    [Abstract] [Full Text] [Related]

  • 2. Effects of caerulein on the gastric motility of rats.
    Jin ZZ, Neya T, Nakayama S.
    Acta Med Okayama; 1985 Dec 12; 39(6):431-40. PubMed ID: 4091039
    [Abstract] [Full Text] [Related]

  • 3. Further studies on the role of cholecystokinin-A and B receptors in secretion of anterior pituitary hormones in male rats.
    Peuranen E, Vasar E, Koks S, Volke V, Lang A, Rauhala P, Männistö PT.
    Neuropeptides; 1995 Jan 12; 28(1):1-11. PubMed ID: 7746348
    [Abstract] [Full Text] [Related]

  • 4. Effect of intracerebroventricular and systemic injections of caerulein, a CCK analogue, on electrical self-stimulation and its interaction with the CCKA receptor antagonist, L-364,718 (MK-329).
    Hamilton MH, Rose IC, Herberg LJ, de Belleroche JS.
    Psychopharmacology (Berl); 1990 Jan 12; 101(3):384-9. PubMed ID: 2362955
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Long-lasting inhibitory action of caerulein on climbing fiber system in the cerebellum of the rat.
    Kageyama H, Kurosawa A.
    Neuropharmacology; 1989 Sep 12; 28(9):991-5. PubMed ID: 2554189
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Vagal afferent-mediated inhibition of a nociceptive reflex by i.v. serotonin in the rat. II. Role of 5-HT receptor subtypes.
    Meller ST, Lewis SJ, Brody MJ, Gebhart GF.
    Brain Res; 1992 Jul 10; 585(1-2):71-86. PubMed ID: 1511336
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Antinociception and cardiovascular responses produced by intravenous morphine: the role of vagal afferents.
    Randich A, Thurston CL, Ludwig PS, Timmerman MR, Gebhart GF.
    Brain Res; 1991 Mar 15; 543(2):256-70. PubMed ID: 2059834
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Changes in GABA content and turnover in discrete regions of rat brain after systemic administration of caerulein.
    Nakamura K, Matsumoto T, Hirano M, Uchimura H.
    Psychopharmacology (Berl); 1990 Mar 15; 101(1):73-6. PubMed ID: 2343075
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Satiety effects of cholecystokinin and caerulein in rabbits.
    Houpt TR, Anika SM, Wolff NC.
    Am J Physiol; 1978 Jul 15; 235(1):R23-8. PubMed ID: 677336
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.